|
Apr 30
|
REFILE-CORRECTED-US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting
|
|
Apr 30
|
US STOCKS-Wall Street ends lower as markets weigh strong wage data, Fed meeting
|
|
Apr 30
|
Stocks End April On Sour Note, Dow Loses 570 Points
|
|
Apr 30
|
US Equity Markets Close Down Tuesday After Higher Wage Data
|
|
Apr 30
|
CORRECTED-US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting
|
|
Apr 30
|
Sector Update: Health Care Stocks Mixed Late Afternoon
|
|
Apr 30
|
US STOCKS-Wall Street stocks fall as markets weigh strong wage data, Fed meeting
|
|
Apr 30
|
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
|
|
Apr 30
|
Taxpayer to fork out £85bn to cover Bank of England losses
|
|
Apr 30
|
Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
|
|
Apr 30
|
Potential for Weight-Loss Drugs Boosts Eli Lilly
|
|
Apr 30
|
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
|
|
Apr 30
|
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings
|
|
Apr 30
|
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
|
|
Apr 30
|
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
|
|
Apr 30
|
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
|
|
Apr 30
|
US STOCKS-Wall St falls on hot labor costs data, caution before Fed verdict
|
|
Apr 30
|
Why Eli Lilly Stock Is Jumping Today
|
|
Apr 29
|
Why these analysts are bullish on healthcare stocks
|
|
Apr 29
|
All Eyes Are on Zepbound Sales as Lilly Reports Earnings
|